Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02120417 | A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer | terminated | Phase 2 | 149 | Incyte CorporationINDUSTRY | 6 | Feb 13, 2018 | clinicaltrials |
| NCT01484041 | Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 12 | Georgetown UniversityOTHER | 1 | Feb 9, 2018 | clinicaltrials |
| NCT01937507 |
| Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer |
| terminated |
| Phase 2 |
| 2 |
| Western Regional Medical CenterOTHER |
| 1 |
| Feb 7, 2018 |
| clinicaltrials |
| NCT00095862 | Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers | terminated | Phase 1 / Phase 2 | 24 | Wiseman Research Initiatives LLCINDUSTRY | 1 | Feb 5, 2018 | clinicaltrials |
| NCT01984892 | Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)(Hiltonol) | terminated | Phase 2 | 8 | Nina BhardwajOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02166658 | A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)(CaBaMet) | terminated | Phase 2 | 8 | AIO-Studien-gGmbHOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02348281 | Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients | terminated | Phase 2 | 1 | Fudan UniversityOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT00864175 | Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 68 | Incyte CorporationINDUSTRY | 1 | Jan 18, 2018 | clinicaltrials |
| NCT01815346 | Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG | terminated | Phase 1 / Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 12, 2018 | clinicaltrials |
| NCT00470548 | Abraxane and Alimta in Advanced Solid Tumors | terminated | Phase 1 / Phase 2 | 49 | University of California, DavisOTHER | 1 | Jan 10, 2018 | clinicaltrials |
| NCT00290654 | Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ | terminated | Phase 2 | 45 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00376805 | Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer | terminated | Phase 2 | 6 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00379197 | Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer | terminated | Phase 2 | 13 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00602446 | Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant | terminated | Phase 2 | 4 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT01372618 | Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor | terminated | Phase 1 / Phase 2 | 9 | NYU Langone HealthOTHER | 1 | Dec 27, 2017 | clinicaltrials |
| NCT00622401 | Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12 | terminated | Phase 1 / Phase 2 | 8 | Beth Israel Deaconess Medical CenterOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT00581529 | Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy | terminated | Phase 2 | 34 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT01512199 | Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC) | terminated | Phase 1 / Phase 2 | 29 | Daiichi SankyoINDUSTRY | 2 | Oct 18, 2017 | clinicaltrials |
| NCT01939418 | Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 23 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 3, 2017 | clinicaltrials |
| NCT00003454 | Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer | terminated | Phase 2 | 19 | Burzynski Research InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT00684216 | Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer | terminated | Phase 2 / Phase 3 | 10 | The Netherlands Cancer InstituteOTHER | 1 | Sep 14, 2017 | clinicaltrials |
| NCT00832338 | Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores | terminated | Phase 2 | 23 | Emory UniversityOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT01319539 | MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | terminated | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Aug 30, 2017 | clinicaltrials |
| NCT02360059 | Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 17, 2017 | clinicaltrials |
| NCT00206492 | Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients | terminated | Phase 2 | 3 | Baylor Breast Care CenterOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT01436604 | Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging(MRTOX) | terminated | Phase 2 | 19 | Centre Francois BaclesseOTHER | 1 | Jul 28, 2017 | clinicaltrials |
| NCT00041470 | Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial | terminated | Phase 1 / Phase 2 | 38 | University of WashingtonOTHER | 1 | Jul 17, 2017 | clinicaltrials |
| NCT00194792 | Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer | terminated | Phase 2 | 28 | University of WashingtonOTHER | 1 | Jul 11, 2017 | clinicaltrials |
| NCT01754519 | Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery | terminated | Phase 2 | 1 | Roswell Park Cancer InstituteOTHER | 1 | Jul 7, 2017 | clinicaltrials |
| NCT01918306 | GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 11 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT01868503 | Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer | terminated | Phase 2 | 7 | Stanford UniversityOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT00088985 | Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer | terminated | Phase 2 | 56 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 20, 2017 | clinicaltrials |
| NCT00638963 | Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)(STOP) | terminated | Phase 2 | 6 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 14, 2017 | clinicaltrials |
| NCT00932035 | Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 39 | City of Hope Medical CenterOTHER | 1 | Jun 7, 2017 | clinicaltrials |
| NCT02322853 | A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors(OLYMPE) | terminated | Phase 2 | 8 | Centre Francois BaclesseOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT00661531 | Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy | terminated | Phase 2 | 11 | Georgetown UniversityOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT01151449 | Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | Apr 11, 2017 | clinicaltrials |
| NCT01729884 | Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer | terminated | Phase 2 | 3 | University of WashingtonOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT00126451 | A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED) | terminated | Phase 2 | 16 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 10, 2017 | clinicaltrials |
| NCT01110954 | Fluorescence-guided Resection in Breast Cancer | terminated | Phase 2 | 8 | photonamic GmbH & Co. KGINDUSTRY | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00176488 | Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | terminated | Phase 2 | 31 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00549822 | Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer | terminated | Phase 2 | 3 | Massachusetts General HospitalOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT00496366 | Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer | terminated | Phase 2 | 11 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 21, 2017 | clinicaltrials |
| NCT00263211 | A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients | terminated | Phase 2 | 48 | Washington University School of MedicineOTHER | 1 | Mar 15, 2017 | clinicaltrials |
| NCT00285857 | Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention | terminated | Phase 2 | 30 | Stanford UniversityOTHER | 1 | Mar 9, 2017 | clinicaltrials |
| NCT01120158 | Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer | terminated | Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01562873 | Ruxolitinib in Patients With Breast Cancer | terminated | Phase 2 | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00904423 | Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption | terminated | Phase 1 / Phase 2 | 8 | Mark PegramOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT00133796 | Neoadjuvant Herceptin in Patients With Breast Cancer | terminated | Phase 2 | 40 | Mothaffar RimawiOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00481845 | Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer | terminated | Phase 2 | 1 | Stanford UniversityOTHER | 1 | Feb 7, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Feb 13, 2018source: clinicaltrials